BOE Importance: 3/10

Dissolution of the Advisory Committee on Growth Hormone and Related Substances in the SNS

29 Apr 2026 Effective: 17 Apr 2026 55 views
Who is affected:
SNS health professionals and patients with growth hormone treatments

Summary

The Ministry of Health extinguishes the Advisory Committee that supervised the use of growth hormone in the National Health System. This consultative body is officially dissolved.

Detailed analysis PRO

The General Directorate of Common Portfolio of SNS Services and Pharmacy declares extinct the Advisory Committee on growth hormone and related substances. This committee had consultative functions regarding the prescription and monitoring of growth hormone treatments financed by the SNS. Its dissolution implies that th…

PRO exclusive content

Implicaciones prácticas, plazos y recomendaciones específicas para tu sector.

Crear cuenta gratis Ver planes PRO

Full official title

Resolución de 17 de abril de 2026, de la Dirección General de Cartera Común de Servicios del Sistema Nacional de Salud y Farmacia, por la que se declara extinguido el Comité Asesor de la hormona de crecimiento y sustancias relacionadas.

View original source (BOE)

Affected sectors

Healthcare

Categories

Tax & Revenue Labour & Employment Corporate & Business Data Protection Social Security European Regulations Grants & Subsidies Other Regulations Public Sector Education Energy Agriculture & Fisheries Real Estate

PRO Plan

Alerts, detailed analysis and private Telegram channel.

From 9.99 EUR/month

Related regulations